CA2015828A1 - Vaccin contre le corona virus canin - Google Patents

Vaccin contre le corona virus canin

Info

Publication number
CA2015828A1
CA2015828A1 CA2015828A CA2015828A CA2015828A1 CA 2015828 A1 CA2015828 A1 CA 2015828A1 CA 2015828 A CA2015828 A CA 2015828A CA 2015828 A CA2015828 A CA 2015828A CA 2015828 A1 CA2015828 A1 CA 2015828A1
Authority
CA
Canada
Prior art keywords
corona virus
canine corona
vaccine
virus vaccine
canine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015828A
Other languages
English (en)
Other versions
CA2015828C (fr
Inventor
William Baxendale
William S.K. Chalmers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2015828A1 publication Critical patent/CA2015828A1/fr
Application granted granted Critical
Publication of CA2015828C publication Critical patent/CA2015828C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
CA 2015828 1989-05-03 1990-05-01 Vaccin contre le corona virus canin Expired - Fee Related CA2015828C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89.304441.2 1989-05-03
EP89304441 1989-05-03

Publications (2)

Publication Number Publication Date
CA2015828A1 true CA2015828A1 (fr) 1990-11-03
CA2015828C CA2015828C (fr) 1999-07-13

Family

ID=8202669

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2015828 Expired - Fee Related CA2015828C (fr) 1989-05-03 1990-05-01 Vaccin contre le corona virus canin

Country Status (12)

Country Link
US (2) US5232694A (fr)
EP (1) EP0396193B1 (fr)
JP (1) JP2892767B2 (fr)
KR (1) KR0142081B1 (fr)
AU (1) AU630186B2 (fr)
CA (1) CA2015828C (fr)
DE (1) DE69014974T2 (fr)
DK (1) DK0396193T3 (fr)
ES (1) ES2068322T3 (fr)
HU (1) HU214739B (fr)
NZ (1) NZ233509A (fr)
ZA (1) ZA903142B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
WO1998027433A1 (fr) * 1996-12-18 1998-06-25 Engene Biotechnologies, Inc Diagnostic specifique des anticorps contre le virus de la peritonite infectieuse feline
AU2005200757A1 (en) * 2005-02-21 2006-09-07 Peter Henry Scott An Insect Attractant Composition and Trap Containing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
EP0138242A1 (fr) * 1983-09-07 1985-04-24 Duphar International Research B.V Procédé pour la préparation d'ADN complémentaire du génome des coronavirus
AU7961487A (en) * 1986-08-22 1988-03-08 University Of Texas System, The Human enteric coronavirus
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine

Also Published As

Publication number Publication date
JP2892767B2 (ja) 1999-05-17
NZ233509A (en) 1992-05-26
DE69014974T2 (de) 1995-05-18
KR0142081B1 (ko) 1998-06-01
HUT56287A (en) 1991-08-28
DK0396193T3 (da) 1995-02-27
HU902644D0 (en) 1990-09-28
DE69014974D1 (de) 1995-01-26
EP0396193B1 (fr) 1994-12-14
KR900017611A (ko) 1990-12-19
ES2068322T3 (es) 1995-04-16
AU5474190A (en) 1990-11-08
ZA903142B (en) 1991-02-27
AU630186B2 (en) 1992-10-22
JPH02295934A (ja) 1990-12-06
US5464621A (en) 1995-11-07
CA2015828C (fr) 1999-07-13
HU214739B (hu) 2000-03-28
US5232694A (en) 1993-08-03
EP0396193A1 (fr) 1990-11-07

Similar Documents

Publication Publication Date Title
HUP9903169A3 (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
CA2076744A1 (fr) Agent viral associe a la maladie mysterieuse du porc
IL92374A0 (en) Skin test and test kit for aids
GB2303854B (en) Helicobacter proteins and vaccines
RU97101084A (ru) Штамм streptococcus equi, микробиологически чистая культура, живая вакцина и способ ее получения
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
CA2134835A1 (fr) Vaccins de virulence attenuee administres in ovo
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
TW340873B (en) Chicken anaemia agent vaccine
CA2015828A1 (fr) Vaccin contre le corona virus canin
CA2273074A1 (fr) Vaccination in ovo contre la maladie de newcastle
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
CA2222482A1 (fr) Mycoplasma synoviae non virulent et vaccin correspondant
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
DE68918649D1 (de) Lebende Newcastle-Krankheit-Virus-Vakzine.
CA2087003A1 (fr) Vaccin anti-vrs humain
CA2176929A1 (fr) Vaccin contre les oreillons contenant une souche virale jeryl-lynn
ES2002100A6 (es) Un procedimiento para preparar una vacuna viva contra la bronquitis infecciosa de aves de corral.
EP0255755A3 (fr) Préparation de vaccin
FR2580176B1 (fr) Vaccin antirabique avirulent
Ristau et al. Bovine leucosis virus challenge infection of calves following application of BL-3 cells
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed